Intrinsic resistance networks shape cefiderocol susceptibility in ST258 Klebsiella pneumoniae
Antimicrobial Agents and Chemotherapy · 2026
DOI: 10.1128/aac.00197-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Kevin J Rome und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Cephalosporins, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Cefiderocol (CFDC) is a siderophore-conjugated cephalosporin developed to overcome multidrug resistance in gram-negative bacteria. Despite its unique iron-dependent entry mechanism, CFDC resistance has emerged in Klebsiella pneumoniae , primarily driven by alterations in siderophore transport and β-lactamase evolution; however, the broader intrinsic resistome that supports CFDC tolerance remains incompletely defined. Here, we performed high-density transposon mutagenesis (Tn-Seq) in the epidemic ST258 K. pneumoniae to map the functional genetic landscape of CFDC susceptibility. Tn-Seq identified siderophore uptake components ( tonB and cirA ) as the dominant determinants of CFDC resistance. In contrast, disruption of genes involved in peptidoglycan recycling ( ampG and ldcA ), synthesis ( mrcB and lpoB ), and enterobacterial common antigen biosynthesis ( wzxE and wzyE ), as well as deletion of plasmid-encoded bla KPC-3 , increased CFDC susceptibility. In a CFDC-resistant Δ tonB strain, targeting these envelope homeostasis pathways yielded only limited resensitization relative to the siderophore-competent parental strain. Deletion of bla KPC-3 produced the greatest increase in susceptibility, reducing the CFDC MIC fourfold. This pattern is consistent with a model in which reduced CFDC influx in the Δ tonB background lowers intracellular drug exposure to levels at which the otherwise limited anti-CFDC activity of KPC β-lactamase becomes sufficient to drive resistance. Together, these data support a multi-layered functional network governing cefiderocol susceptibility in ST258 K. pneumoniae , in which iron-dependent drug uptake constrains intracellular exposure, while β-lactamase activity and intrinsic envelope homeostasis pathways further shape bacterial tolerance once cefiderocol enters the cell.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
- School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.
ORCID-Profile: Kevin J Rome, Austin J Terlecky, Liang Chen, Barry N Kreiswirth
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Rome, K. J., Terlecky, A. J., Yen, K. K., Long, T., Bucich, M. J., Thom, K. V., Shashkina, E., Chen, L., & Kreiswirth, B. N. (2026). Intrinsic resistance networks shape cefiderocol susceptibility in ST258 Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00197-26
Vancouver
Rome KJ, Terlecky AJ, Yen KK, Long T, Bucich MJ, Thom KV, et al. Intrinsic resistance networks shape cefiderocol susceptibility in ST258 Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.00197-26
BibTeX
@article{Rome2026,
author = {Rome, Kevin J and Terlecky, Austin J and Yen, Kelly K and Long, Tengfei and Bucich, Mia J and Thom, Klara V and Shashkina, Elena and Chen, Liang and Kreiswirth, Barry N},
title = {Intrinsic resistance networks shape cefiderocol susceptibility in ST258 Klebsiella pneumoniae},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.00197-26}
}
EUVIMED